Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 11  |  Issue : 44  |  Page : 501-510

Cucumis melo ssp. Agrestis var. Agrestis Ameliorates High Fat Diet Induced Dyslipidemia in Syrian Golden Hamsters and Inhibits Adipogenesis in 3T3-L1 Adipocytes


1 Division of Pharmacology, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
2 Division of Botany, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
3 Division of Pharmacology, CSIR Central Drug Research Institute; Academy of Scientific and Innovative Research, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
4 Division of Toxicology, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
5 Sophisticated Analytical Instrument Facility, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
6 Division of Botany, CSIR Central Drug Research Institute; Division of Pharmacology, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India

Correspondence Address:
Anil N Gaikwad
BS 10/1, Sector 10, PCN 208, Division of Pharmacology, CSIR- Central Drug Research Institute, Jankipuram Extension, Lucknow 226 031, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1296.172945

Rights and Permissions

Background: Cucumis melo ssp. agrestis var. agrestis (CMA) is a wild variety of C. melo. This study aimed to explore anti-dyslipidemic and anti-adipogenic potential of CMA. Materials and Methods: For initial anti-dyslipidemic and antihyperglycemic potential of CMA fruit extract (CMFE), male Syrian golden hamsters were fed a chow or high-fat diet with or without CMFE (100 mg/kg). Further, we did fractionation of this CMFE into two fractions namely; CMA water fraction (CMWF) and CMA hexane fraction (CMHF). Phytochemical screening was done with liquid chromatography-mass spectrometry LC- (MS)/MS and direct analysis in real time-MS to detect active compounds in the fractions. Further, high-fat diet fed dyslipidemic hamsters were treated with CMWF and CMHF at 50 mg/kg for 7 days. Results: Oral administration of CMFE and both fractions (CMWF and CMHF) reduced the total cholesterol, triglycerides, low‐density lipoprotein cholesterol, and very low‐density lipoprotein-cholesterol levels in high fat diet-fed dyslipidemic hamsters. CMHF also modulated expression of genes involved in lipogenesis, lipid metabolism, and reverse cholesterol transport. Standard biochemical diagnostic tests suggested that neither of fractions causes any toxicity to hamster liver or kidneys. CMFE and CMHF also decreased oil-red-O accumulation in 3T3-L1 adipocytes. Conclusion: Based on these results, it is concluded that CMA possesses anti-dyslipidemic and anti-hyperglycemic activity along with the anti-adipogenic activity.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1513    
    Printed34    
    Emailed0    
    PDF Downloaded19    
    Comments [Add]    
    Cited by others 1    

Recommend this journal